Dog Cancer Cure Holds New Hope. Today cancer is the leading cause of death in dogs. Nearly 50% or half of all dogs age 10 and over die from cancer. That represents approximately 6 million canine lives lost each year from cancer. [Conversely 1.7 million Americans are diagnosed with cancer each year and 600,000 lives are lost as a result.] Traditional options for pets with cancer have been limited to various combinations of surgery, chemotherapy, and radiation. Success rates for the last 20 plus years have flat lined with less than 3 percent of patients achieving a cure.
Cancer Immunotherapy is one of the newest, most promising areas of cancer research available today. Facebook’s former president Sean Parker, recently donated $250 million dollars to boost human Immunotherapy Cancer Research. Today, new hope is on the horizon for pet cancer immunotherapy as well. Biotempus researchers headed up by Dr. Noam Pik in Australia have mapped the canine immune system and discovered an algorithm that allows them to manipulate the dog’s own immune system to target and kill cancer cells.
By measuring the daily concentration of an inflammatory blood marker called C-Reactive Protein [CRP] researchers have been able to pinpoint the optimal day and time to give a single oral dose of a chemotherapeutic agent that so far has cured canine cancer in a handful of dogs. Currently, dogs with bone cancer referred to as Osteosarcoma and Melanoma have achieved remission. Although cancer immunotherapy is currently only approved for an experimental therapy of last resort for terminal, end-stage cancer patients, results are very promising, holding hope to potentially save millions of lives both 2 and 4 footed.
Dog owners of canines with terminal cancer interested in more information on the Canine Immunotherapy Clinical Trials being offered by veterinarian Carol Osborne and the Chagrin Falls Pet Clinic can call 1-866-372-2765 or log onto https://www.chagrinfallspetclinic.com
